Overview
Lajos Pusztai is an Oncologist in New Haven, Connecticut. Dr. Pusztai is highly rated in 7 conditions, according to our data. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Tissue Biopsy.
His clinical research consists of co-authoring 385 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Humana
Locations
20 York St, New Haven, CT 06510
800 Howard Ave, New Haven, CT 06519
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Yale University
Francine Foss is an Oncologist and a Hematologist Oncology provider in New Haven, Connecticut. Dr. Foss is highly rated in 32 conditions, according to our data. Her top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Non-Hodgkin Lymphoma, and Bone Marrow Transplant.
Yale University
Scott Gettinger is an Oncologist and a Hematologist in New Haven, Connecticut. Dr. Gettinger has been practicing medicine for over 26 years is highly rated in 16 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Gamma Knife Radiosurgery.
Yale University
Harriet Kluger is an Oncologist and a Hematologist in New Haven, Connecticut. Dr. Kluger is highly rated in 21 conditions, according to our data. Her top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Merkel Cell Carcinoma, Metastatic Brain Tumor, and Nephrectomy.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Inflammatory Breast Cancer
- Advanced
- Angiosarcoma
- HER-2 Positive Breast Cancer
- HER2 Negative Breast Cancer
- Paget Disease of the Breast